Skip to content

Clinical trials

Lung Neoplasms trials in Romania

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Country / region: Romania Clear all

45 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20062
20073
20083
20091
20103
20114
20121
20142
20152
20163
20201
20211
20222
20233
20244
20257
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Recruiting11
Active, not recruiting6
Terminated5
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb5
Amgen4
Eli Lilly and Company4
Merck Sharp & Dohme LLC4
AstraZeneca3
BioNTech SE2
Novartis Pharmaceuticals2
Pfizer2
CSL Behring1
Daiichi Sankyo1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms45
Carcinoma, Non-Small-Cell Lung27
Neoplasms5
Carcinoma4
Breast Neoplasms3
Lung Diseases3
Anemia2
Cachexia2
Neoplasm Metastasis2
Ovarian Neoplasms2

Trials

Showing 26 to 45 of 45. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.